What to Check When a Research Peptide Order Arrives

A box arrives. Inside are a few small glass vials with coloured caps, each holding what looks like a scrap of white material, and a sheet of paper or a link to one. Five minutes spent on the right checks at this point is worth more than any amount of checking later, because this is the only moment when the shipment, the labels and the documentation are all in front of you at once and nothing has been opened.

This article sets out what to look at, what the recognised defects in a freeze-dried cake actually are and what they do and do not tell you, and which documentation checks have real standards behind them. Those standards were written for pharmaceutical manufacturing and for accredited testing laboratories, not for research reagents, and we flag the scope every time, because borrowing a benchmark is useful and pretending to be bound by one is not.

Start with the batch number

Before looking at the material, look at the two numbers. The batch or lot number printed on the vial label, and the batch or lot number on the certificate of analysis. If they do not match, the certificate is a document about different material, and nothing it says applies to what you are holding.

That is not a pedantic point; it is the formal position of the accreditation standard that governs testing laboratories. Clause 7.8.2.1 l) of ISO/IEC 17025:2017 requires a test report to carry a statement to the effect that the results relate only to the items tested. We are paraphrasing rather than quoting, because the standard’s text is not free to reproduce, but the clause and its substance are confirmed by the European co-operation for Accreditation and by a NIST crosswalk of the standard. The European co-operation for Accreditation goes further and holds that the statement is needed in all test reports and cannot be waived even by written agreement with the customer, precisely so that results are not extended to other items.

Two scope notes. ISO/IEC 17025 binds the testing laboratory, not the supplier and not you. And a certificate written by a vendor is not an accredited laboratory report, so the clause does not reach it directly. What transfers is the logic: a report describes the material that was sampled and nothing else. Our COA guide covers what else a useful certificate should contain, and lot numbers and batch traceability goes into the identifiers in depth.

What the cake can and cannot tell you

A lyophilized peptide should present as a dry cake or powder. Buyers tend to read a great deal into exactly how it looks, and the literature supports reading rather less.

Appearance is a genuine quality attribute. A 2024 study in AAPS PharmSciTech on automated assessment of structural defects in freeze-dried pharmaceuticals notes that “as structural defects significantly impact the lyophilisate quality, freeze-dried products undergo routine visual inspections”. FDA’s inspection guide for lyophilized parenterals likewise lists among critical aspects “the presence of correct volume of cake and the cake appearance”.

But the same 2024 paper is explicit about the limit of that inspection, and this is the sentence to hold onto: other attributes “can be more crucial in practical applications than the product’s appearance”, and “ultimately, the decisive factor is the quality of the reconstituted lyophilisate rather than its visual characteristics”. Neither source we read claims that appearance measures content or potency, and we are not going to imply it does.

The recognised defects

The vocabulary here comes from two different sources and is worth attributing properly rather than presenting as a single canonical list.

Two attributions matter. “Meltback” is FDA’s term, defined in its 1993 inspection guide for lyophilized parenterals as a form of collapse rather than as a separate category; the 2024 paper does not use the word at all and treats shrinkage and collapse as one category. FDA also states that its guide does not bind the agency, and both sources concern parenteral drug manufacture rather than research reagents. Of the five, meltback is the one worth taking most seriously on receipt, because of the moisture association.

Water, and why it is the real variable

The thread running through the defect literature is not appearance but moisture. FDA’s association of meltback with “a pocket of moisture” and with “greater instability and increased product degradation” is the mechanism that makes a visual check worth doing at all.

Water content in a lyophilized material is measured, not estimated by eye. The compendial approach is titrimetric: the United States Pharmacopeia’s general chapter on water determination gives a titrimetric method as Method I, using a reagent containing sulfur dioxide and iodine, which is Karl Fischer titration. The chapter notes that the underlying reaction stoichiometry is not exact, so the procedure has to be empirically standardised, and that precision depends largely on excluding atmospheric moisture during the determination. We cite that chapter by number and title only: the copy we could read was a mirror of an older edition, so we are not attributing a current-edition page or year to it.

What we are deliberately not giving you is a number. We found no verifiable residual-moisture limit or typical percentage for research peptides, so quoting one would be invention. If water content appears on your certificate, that is a genuinely informative line; if it does not, no visual check substitutes for it. Our articles on what lyophilized means and peptide storage cover the handling side.

Lot numbers and retest dates

Two definitions are worth knowing because they change what you expect a number to do.

A lot number is defined by capability, not by format. The US regulation, 21 CFR 210.3(b)(11), defines it as “any distinctive combination of letters, numbers, or symbols, or any combination of them, from which the complete history of the manufacture, processing, packing, holding, and distribution of a batch or lot of drug product or other material can be determined”. Canada’s Food and Drug Regulations take the same functional approach at section A.01.010: a lot number is any combination of letters, figures or both by which a food or drug “can be traced in manufacture” and “identified in distribution”. On both definitions, a string that nothing can be looked up against does not do the job, however official it looks. Note the scope: 21 CFR 210.3 is US current good manufacturing practice for drug products, and A.01.010 applies to foods and drugs under Canada’s Food and Drugs Act. Neither governs a research-use-only reagent, so both are definitional parallels rather than rules you can invoke.

A retest date is not an expiry date with a different name. ICH Q7’s glossary defines it as “the date when a material should be re-examined to ensure that it is still suitable for use”, and the guideline notes at section 11.61 that for active ingredients “common practice is to use a retest date, not an expiration date”. The same glossary defines a batch or lot number as a unique combination of numbers, letters and symbols identifying a batch “and from which the production and distribution history can be determined” — the same traceability logic again. ICH Q7 governs active pharmaceutical ingredients for medicinal use; a research reagent is not an API, and Q7 does not apply to it.

What a test report actually covers

One more standard is worth borrowing, with its scope stated clearly. The United States Pharmacopeia’s general chapter on visible particulates in injections opens “all products intended for parenteral administration must be visually inspected for the presence of particulate matter”, and defines particulate matter as extraneous mobile undissolved particles other than gas bubbles, giving examples such as fibres, glass, metal, elastomers and precipitates.

That chapter is useful to a research buyer as vocabulary and nothing more. It is written for injectable drug products, which a research-use-only reagent is not, and its criteria are framed around inspecting a solution rather than a dry cake — so it is not a test you can apply to a powder and not an obligation you are under. What it does give you is a precise shared language for describing something you can see in a vial, which makes a supplier conversation shorter.

Documentation in a Canadian workplace

If the material is going into a workplace in Canada and it is classified as a hazardous product under the Hazardous Products Regulations, safety data sheet expectations attach. The Canadian Centre for Occupational Health and Safety states that safety data sheets must be provided by suppliers of hazardous products at the time of sale, in English and French, and that employers must ensure hazardous products have an up-to-date sheet when the product enters the workplace.

One widely repeated rule is out of date and worth correcting: suppliers are no longer required to update a safety data sheet every three years. The current supplier duty is to update within 90 days of becoming aware of significant new data. A three-year employer refresh duty still exists in some Canadian jurisdictions and not others, so a pan-Canadian statement of a single interval would be wrong.

Two scope limits, stated plainly. This applies only if the product is actually classified as hazardous under the regulations, and only where there is a workplace. We did not verify whether any laboratory-sample or research-reagent exemption applies, so we are not claiming one either way. Our articles on peptide lab safety under WHMIS and COA versus SDS versus specification sheet cover the document types.

Temperature on arrival, honestly

This is the question we are asked most and the one with the least published support, so here is the honest answer rather than a comforting one.

We searched specifically for a sourced tolerance window — how warm a lyophilized peptide powder can get, and for how long, before it matters — and found nothing in primary or peer-reviewed literature. The only results were vendor pages and content-marketing articles. We are therefore not going to tell you that a powder is fine at room temperature for any particular number of days, and we would treat any supplier who gives you a confident figure without a citation with some caution.

What is supportable is narrower and still useful. The stability concern in the freeze-drying literature attaches to moisture rather than to a transit temperature: FDA’s association of a moisture pocket with greater instability and increased degradation is about water, not warmth. So the defensible position is that the supplier’s stated storage condition and the certificate govern, that a lyophilized powder and a solution are not the same stability problem, and that a visibly compromised or badly delayed shipment is a contact-the-supplier event rather than something to judge by eye. Our article on shipping through a Canadian winter covers the seasonal end of this.

What’s established and what isn’t

The checklist

In the order that makes the most of the five minutes.

• Match the numbers. Batch or lot on the vial against batch or lot on the certificate. If they differ, stop and ask.
• Count and read the labels. Compound name, batch, and any retest or expiry date, against what you ordered.
• Look at each cake against the defect vocabulary above. Note anything unusual, photograph it, and keep the photograph with the paperwork.
• Read the certificate for what it reports, not just the headline number: identity by mass, purity with its method, and water content if present.
• Check the documentation set, including a current safety data sheet if the product is a hazardous product going into a workplace.
• Store it as the supplier specifies, and record the date you received it so a retest date means something later.

Research peptides with published test reports

These are products whose listing links a report. Janoshik Analytical certificates for most research products are listed by batch on our Lab Testing page (the rest are available on request), so the batch-matching check above can be done before you order as well as after.

BPC-157Supplied lyophilized, with batch-listed reportsView product GHK-CuCopper tripeptide, supplied as a saltView product TB-500 (Thymosin Beta-4)Check the measured mass on the reportView product KPVA tripeptide, listed with batch reportsView product

Frequently asked questions